MSI Financial Services’s PDL BioPharma, Inc. PDLI Stock Holding History

MSI Financial Services’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$10K	Sell	4,800 -3,882	-45%	-$10.8K	﹤0.01%	2835
2016 Q3	$29K	Buy	8,682 +4	+0%	+$13	﹤0.01%	2164
2016 Q2	$27K	Buy	8,678 +100	+1%	+$333	﹤0.01%	2180
2016 Q1	$29K	Buy	8,578 +3,000	+54%	+$9.35K	﹤0.01%	2099
2015 Q4	$20K	Buy	+5,578	New	+$23.3K	﹤0.01%	2327
2015 Q3	–	Sell	-3,085	Closed	-$20K	–	3591
2015 Q2	$20K	Sell	3,085 -521	-14%	-$3.49K	﹤0.01%	1807
2015 Q1	$25K	Sell	3,606 -1,094	-23%	-$7.92K	﹤0.01%	1705
2014 Q4	$36K	Buy	+4,700	New	+$37.2K	﹤0.01%	1233

Other funds holding PDLI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MSI Financial Services's PDLI Position: Q4 2016 in Review

MSI Financial Services reduced its PDL BioPharma, Inc. (PDLI) stake by 45% in Q4 2016, selling an estimated $10.8K and leaving 4,800 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #2835.

MSI Financial Services first reported a position in PDLI in Q4 2014 and has held it in 8 quarters since. The position peaked at $36K in Q4 2014. 190 funds tracked by Wall St. Rank hold PDLI as of Q4 2016.

MSI Financial Services held 4,800 shares of PDL BioPharma, Inc. worth $10K as of Q4 2016.
MSI Financial Services sold 3,882 PDL BioPharma, Inc. shares in Q4 2016, an estimated $10.8K.
PDL BioPharma, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2835 holding.
MSI Financial Services first reported a position in PDL BioPharma, Inc. in Q4 2014 and has held it in 8 quarters since.
MSI Financial Services's PDL BioPharma, Inc. position peaked at $36K in Q4 2014.
190 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.